Advertisement

Fluorouracil Injection

[06 April 2016]

Products Affected - Description

Fluorouracil injection, Accord
50 mg/mL, 10 mL vial, 10 count (NDC 16729-0276-68)
50 mg/mL, 50 mL vial, 1 count (NDC 16729-0276-11)
50 mg/mL, 100 mL vial, 1 count (NDC 16729-0276-38)
 
Fluorouracil injection, Fresenius Kabi
50 mg/mL, 20 mL vial, 10 count (NDC 63323-0117-20)
 
Fluorouracil injection, Teva
50 mg/mL, 10 mL vial, 10 count (NDC 00703-3015-13)
50 mg/mL, 50 mL vial, 5 count (NDC 00703-3018-12)
50 mg/mL, 100 mL vial, 5 count (NDC 00703-3019-12)

Reason for the Shortage

  • Accord cannot provide a reason for the shortage.
  • Fresenius Kabi states the reason for the shortage is increased demand.
  • Teva states the reason for the shortage is increased demand.

Available Products

Fluorouracil injection, Accord
50 mg/mL, 20 mL vial, 10 count (NDC 16729-0276-67)
 
Fluorouracil injection, Fresenius Kabi
50 mg/mL, 10 mL vial, 10 count (NDC 63323-0117-10)
50 mg/mL, 50 mL vial, 1 count (NDC 63323-0117-51)
50 mg/mL, 100 mL vial, 1 count (NDC 63323-0117-61)

Estimated Resupply Dates

  • Accord has fluorouracil 10 mL, 50 mL, and 100 mL vials on back order and the company estimates a release date of April 2016.
  • Fresenius Kabi has fluorouracil 50 mL vials on back order and the company estimates a release date of early-April 2016.
  • Teva has fluorouracil 10 mL, 50 mL, and 100 mL vials available on allocation.

Related Shortages

Updated

April 6, March 28, 22, 14 and 4, February 25, January 28, 2016, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing